Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02500901
Title Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors Paul Mathew, MD
Age Groups: adult
Covered Countries USA

No variant requirements are available.